SignalEU/UK

Merck Says Investigational Diabetes-Related Blindness Drug at Par With Roche’s Medicine

Merck's drug matches Roche's, signaling competitive diabetes-blindness treatment data.

What changed

Merck's drug matches Roche's, signaling competitive diabetes-blindness treatment data.

Why it matters

Merck's drug matches Roche's, signaling competitive diabetes-blindness treatment data. — impact context not separately stored; see What changed.

Sources